From Information Overload to Meaningful Insight: Helping Oncologists Make Confident Treatment Decision
In today’s fast-paced oncology environment, physicians are tasked with making complex treatment decisions while navigating an ever-expanding body of clinical data. As Dr. Jessicca Rege shares in the video, the challenge isn’t access to information, it’s finding information that’s useful, relevant, and aligned with a specific patient’s clinical context. Every week brings new trial results, updated guidelines, and shifting regulatory approvals. For oncologists managing dozens of patient cases, keeping up isn’t just time-consuming, it’s nearly impossible without the right tools. That’s where Oncoscope-AI steps in. Built for the real-world demands of cancer care, our platform transforms data into real-time, patient-specific insights. By combining the speed of AI with the clinical rigor of expert human review, we help oncology teams focus on what matters: making confident, evidence-based decisions at the point of care. The future of cancer treatment isn’t just about more data, it’s about meaningful data. And it’s about time clinicians had the support they need to cut through the noise and focus on what drives outcomes. Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
Why Oncologists Need More Than Guidelines, They Need Living Intelligence
Clinical guidelines are an essential foundation in oncology, but they’re not enough. As Dr. Jessicca Rege highlights in the video, by the time guidelines are published, they often lag behind the most current clinical trial results, emerging biomarkers, and FDA approvals. In a field evolving as quickly as oncology, even the best guidelines can feel outdated the moment they’re released. What oncologists need isn’t just a static reference point, they need living, adaptive tools that evolve in real time. That’s the power of Oncoscope-AI, a platform that bridges the gap between traditional guidelines and cutting-edge clinical intelligence. It continuously ingests and synthesizes the latest trial data, guideline updates, and regulatory changes, then applies expert human review to ensure clinical relevance. The result? A dynamic, reliable source of information that keeps up with the pace of oncology and with the needs of every patient. When treatment decisions can’t wait, Oncoscope-AI gives you the latest data so you’re never relying on yesterday’s evidence. Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
A New Approach for Oncology Decision Support
In oncology, change doesn’t wait. Clinical trial data evolves by the hour, guidelines shift rapidly, and regulatory approvals are updated in real time. For practicing oncologists seeing 20–30 patients a day, staying “up to date” often feels like an impossible task. Traditional tools simply weren’t built for the speed or complexity of modern cancer care. As Dr. Sarkisian shares in his recent discussion, the challenge isn’t just access to information, it’s access to the right information, when it matters. Sifting through endless trial abstracts, publications, and guidelines leaves little room for practical, real-time decision-making. And the cost of delay isn’t theoretical, it impacts lives. That’s where Oncoscope-AI comes in. By combining the speed of AI with the clinical judgment of expert human reviewers, Oncoscope-AI filters, organizes, and prioritizes the most relevant oncology data daily. It’s not just another search tool or chatbot. It’s a decision support platform purpose-built to meet oncologists where they are: at the point of care, under pressure, and in need of trusted, clinically aligned information. In less than three clicks, physicians can access: Physicians know, real-time decisions demand real-time data; anything less puts patients at risk. Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
Real-World Relevance: Dr. Chad Levitt on AI That Works for Doctors
What does meaningful innovation look like in oncology? Dr. Chad Levitt believes it’s not just about new technology, it’s about how we use it. In this video, he shares a clinician’s perspective on what makes AI valuable at the point of care: relevance, clarity, and trust. With clinical teams already overwhelmed by fragmented, constantly evolving oncology data, what they don’t need is more information. What they do need is the right information. And they need it delivered in a way that fits their clinical workflows and supports real-time treatment decisions. That’s the vision behind Oncoscope-AI, a hybrid platform that combines the speed of artificial intelligence with the insight of expert human review. It’s designed specifically for oncology teams, not just to summarize data, but to organize, interpret, and prioritize it with clinical nuance. Dr. Levitt’s message is clear, Tools like Oncoscope aren’t here to replace clinicians. They’re here to support them in doing what they do best, making confident, evidence-based decisions for their patients. “We don’t need more noise. We need intelligent filtering. That’s what makes AI useful in practice, not just possible in theory.” – Dr. Chad Levitt Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
Dr. Saro Sarkisian: Oncology Needs More Than Static Resources
In today’s oncology landscape, the pace of change is staggering. Clinical trials, FDA approvals, and updated guidelines happen constantly. Yet many oncologists are still relying on resources that are static or quickly outdated. Dr. Saro Sarkisian, a practicing medical oncologist, knows this challenge firsthand. In this short video, he explains the frustration clinicians face when trying to make time-sensitive treatment decisions using tools that haven’t kept pace with the data. Traditional references like UpToDate can offer an overview, but in oncology, “up to date” isn’t always current enough. That’s why Oncoscope-AI is a game changer. Oncoscope-AI is a hybrid decision-support platform built specifically for oncologists. It combines the speed and reach of AI with the critical oversight of expert human reviewers. The result? Evidence-based treatment intelligence that’s updated daily, organized by patient profile, and ready to use in clinical decision-making. As Dr. Sarkisian puts it: “We need tools that reflect how fast oncology is evolving, something that doesn’t just tell us what was true last year, but what’s happening now.” If you’re an oncologist navigating today’s complex treatment environment, real-time data isn’t a luxury, it’s a necessity. Beka Vinogradov is the Digital Communications Lead for Oncoscope-AI. She holds a Master’s in Health Administration and has extensive experience and education in business, marketing, and design.
AI In Oncology: Living Guidelines
How are oncology practitioners integrating AI into their clinical workflows? What does it look like to use a living guideline tool in real-world practice?
Breast Cancer, Precision Medicine and AI
This multidisciplinary discussion explores how the convergence of patient advocacy, clinical expertise, and technological innovation can drive more effective and personalized approaches to breast cancer treatment.